Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study - Généreux - 2017 - Catheterization and Cardiovascular Interventions - Wiley Online Library
PDF) The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: A clinical conundrum
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Rapamune (Sirolimus) Market Share, Size 2020 By Industry Future Demand, Global Research, Top Leading Players, Developing Trends, Region Forecast To 2026 | News Break
Bernardo Cortese M.D. - Page 10 of 22 - Interventional Cardiologist
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction | SpringerLink
60145-x.fp.png "INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology")
INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology
Cangrelor compared with clopidogrel improves efficiency without incre…
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study - Tamez - 2018 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Cardiovascular Medicine - Current trends in dual antiplatelet therapy: a 2017 update
Usefulness of Intravascular Ultrasound for Predicting Risk of Intraprocedural Stent Thrombosis. | Semantic Scholar
Cathlab & Cardiovascular News
Acute myocardial infarction - The Lancet
Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
Intra-Procedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes | JACC: Cardiovascular Interventions
Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent - ScienceDirect
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks - ScienceDirect
PCI for STEMI - The Cardiology Advisor
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
